Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroids.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Anakinra (Primary)
- Indications Bursitis; Inflammation; Plantar fasciitis; Tennis elbow
- Focus Therapeutic Use
- 02 Mar 2015 New trial record